Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Indivior (INDV) Share Price

Price 735.00p on 28-03-2025 at 18:35:58
Change -21.50p -2.84%
Buy 733.00p
Sell 731.50p
Buy / Sell INDV Shares
Last Trade: Unknown 1.00 at 746.94198p
Day's Volume: 304,572
Last Close: 735.00p
Open: 769.50p
ISIN: GB00BN4HT335
Day's Range 727.00p - 769.50p
52wk Range: 555.00p - 1,751.00p
Market Capitalisation: £916m
VWAP: 738.56269p
Shares in Issue: 125m

Indivior (INDV) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 1 746.94198p Cross
Currency Conversion
OTC Trade
18:35:57 - 28-Mar-25
Unknown* 100 744.14508p Currency Conversion
OTC Trade
18:24:40 - 28-Mar-25
Unknown* 200 744.42322p Currency Conversion
OTC Trade
18:24:40 - 28-Mar-25
Sell* 177,059 735.00p Uncrossing Trade
16:35:23 - 28-Mar-25
Buy* 19 732.50p Automatic Execution
16:28:13 - 28-Mar-25
Buy* 85 732.50p Automatic Execution
16:28:13 - 28-Mar-25
Buy* 27 732.50p Automatic Execution
16:28:13 - 28-Mar-25
Buy* 19 732.00p Automatic Execution
16:28:13 - 28-Mar-25
Buy* 6 731.50p Automatic Execution
16:27:59 - 28-Mar-25
Buy* 94 731.50p Automatic Execution
16:27:51 - 28-Mar-25
See more Indivior trades

Indivior (INDV) Share Price History

Time period:
to
Date Open High Low Close Volume
28th Mar 2025 (Fri) 769.50 769.50 727.00 735.00 304,572
27th Mar 2025 (Thu) 738.00 768.50 729.50 756.50 270,651
26th Mar 2025 (Wed) 735.50 755.00 734.00 745.50 262,217
25th Mar 2025 (Tue) 791.00 791.00 744.50 744.50 399,763
24th Mar 2025 (Mon) 750.00 775.50 750.00 773.00 228,603
21st Mar 2025 (Fri) 751.50 755.50 721.50 750.50 458,011
20th Mar 2025 (Thu) 784.00 784.00 750.00 758.50 248,936
19th Mar 2025 (Wed) 754.50 770.50 742.50 764.50 197,350
18th Mar 2025 (Tue) 769.50 776.50 742.00 750.00 225,817
17th Mar 2025 (Mon) 742.50 757.50 738.00 751.00 226,974
14th Mar 2025 (Fri) 741.50 764.50 737.00 750.00 279,762
13th Mar 2025 (Thu) 733.50 756.00 733.50 736.50 313,356
12th Mar 2025 (Wed) 760.50 780.50 745.00 749.50 224,629
11th Mar 2025 (Tue) 708.00 745.00 690.50 740.50 408,095
10th Mar 2025 (Mon) 728.50 747.00 702.00 713.50 475,741
7th Mar 2025 (Fri) 775.00 775.00 727.00 727.50 357,030
6th Mar 2025 (Thu) 775.50 783.50 734.50 762.00 271,731
5th Mar 2025 (Wed) 790.50 809.00 746.00 755.00 489,546
4th Mar 2025 (Tue) 748.00 761.50 719.50 722.50 397,461
3rd Mar 2025 (Mon) 716.00 773.50 716.00 753.50 372,825
See more Indivior price history

Indivior (INDV) Regulatory News

Date Source Headline
28th Mar 2025 8:33 am RNS Holding(s) in Company
27th Mar 2025 2:00 pm RNS Notice of AGM
21st Mar 2025 3:40 pm RNS Holding(s) in Company
17th Mar 2025 1:25 pm RNS Director/PDMR Shareholding
17th Mar 2025 1:17 pm RNS Annual Financial Report
14th Mar 2025 3:44 pm RNS Director/PDMR Shareholding
14th Mar 2025 10:03 am RNS Holding(s) in Company
11th Mar 2025 12:41 pm RNS Director/PDMR Shareholding
11th Mar 2025 10:18 am RNS Director/PDMR Shareholding
10th Mar 2025 5:39 pm RNS Director/PDMR Shareholding
See more Indivior regulatory news

Indivior (INDV) Share News

Indivior shrinks size of board after US primary listing

4th Mar 2025 13:35

(Alliance News) - Indivior PLC on Tuesday said it is reducing the size of its board to seven following its US primary listing last year. Read More

IN BRIEF: Incoming Indivior CEO Ciaffoni, other directors buy shares

28th Feb 2025 14:06

Indivior PLC - Richmond, Virginia-based maker of medicines to treat substance use - Non-Executive Director Joe Ciaffoni buys 56,000 shares at USD8.96, worth USD501,519, on Thursday. Indivior on Thursday named Ciaffoni as its next chief executive officer, replacing Mark Crossley. The handover is expected to be after Indivior's annual general meeting in May. Indivior said Crossley is stepping down "by mutual agreement" and "following a distinguished tenure" as CEO since 2020. Crossley joined the board in December, and the 56,000 shares are his first holding. Most recently, he was CEO of Nasdaq-listed Collegium Pharmaceutical Inc. Read More

IN BRIEF: Indivior names former Collegium Pharmaceutical chief as CEO

27th Feb 2025 14:46

Indivior PLC - Richmond, Virginia-based maker of medicines to treat substance use - Appoints Non-Executive Director Joe Ciaffoni as chief executive officer, replacing Mark Crossley. The handover is expected to be after Indivior's annual general meeting in May. Indivior says Crossley is stepping down "by mutual agreement" and "following a distinguished tenure" as CEO since 2020. Crossley joined the board in December. Most recently, he was CEO of Nasdaq-listed Collegium Pharmaceutical Inc. Read More

LONDON BROKER RATINGS: Morgan Stanley raises B&M but Goldman cuts

25th Feb 2025 09:45

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

LONDON BRIEFING: FTSE 100 called red as Starmer prepares to meet Trump

25th Feb 2025 07:52

(Alliance News) - London stocks were called lower on Tuesday, with the data docket including US consumer confidence and the Redbook index. Read More

See more Indivior news
FTSE 100 Latest
Value8,658.85
Change-7.27

Login to your account

Forgot Password?

Not Registered